Literature DB >> 29336221

Sequelae of Tympanostomy Tubes in a Multihospital Health System.

Reema Padia1, Daniel Hall2, Phayvanh Sjogren1, Prem Narayanan2, Jeremy D Meier1.   

Abstract

Objectives Review the incidence of long-term sequelae after placement of tympanostomy tubes. Study Design Case series with chart review. Setting Multihospital network. Subjects Patients 0 to 3 years old undergoing tympanostomy tube (TT) placement. Methods A case series of 14,058 children between 2004 and 2010 was reviewed. The patients were followed for 5 years to determine number of repeated tube placements, need for surgical removal of tubes, and presence of perforation requiring repair. Results The study cohort included 14,058 children who underwent TT placement. The mean age at time of procedure was 1.4 years. A total of 14.4% of patients required a second set of tubes within the 5 years of follow-up studied, and 4.6% required 3 or more sets. Three percent required removal of a tube, and this occurred at an average time of 34.2 ± 17.6 months postplacement. In total, 5.1% had a resulting perforation after either tube extrusion or tube removal requiring myringoplasty. Conclusions The rate of multiple tube placements and myringoplasty and tympanoplasty to correct resulting perforations has yet to be studied in a single large population. This information allows for more detailed preoperative counseling to patients and families. Better characterization of these populations with accurate rates of sequelae can help to tailor treatment and preoperative counseling in the future.

Entities:  

Keywords:  myringoplasty; perforation; retained tubes; tympanoplasty; tympanostomy tube

Mesh:

Year:  2018        PMID: 29336221     DOI: 10.1177/0194599817752633

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Long-Term Otitis Media Outcomes in Infants With Early Tympanostomy Tubes.

Authors:  Kimberly Luu; James Park; Amber D Shaffer; David H Chi
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-16       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.